Xu X, Yang J, Cai Y, Li S, et al. Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem Bone Marrow Transplant 2020 Sep 1. pii: 10.1038/s41409-020-01047.
PMID: 32873913